| Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies (NCT02410252) | Massachusetts General Hospital | 2015-05-01 |
| PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients (NCT02104427) | GPCR Therapeutics, Inc. | 2015-02-01 |
| Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) (NCT02287311) | Baylor College of Medicine | 2015-02-01 |
| Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies (NCT02290951) | Regeneron Pharmaceuticals | 2015-01-09 |
| Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma (NCT02180711) | Acerta Pharma BV | 2014-12-29 |
| Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02129582) | Case Comprehensive Cancer Center | 2014-11-05 |
| Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas (NCT02280785) | Samsung Medical Center | 2014-11-01 |
| Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS (NCT02339805) | Centre Henri Becquerel | 2014-11-01 |
| Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy (NCT02229682) | Sun Yat-sen University | 2014-10-01 |
| Carfilzomib Plus Belinostat in Relapsed/Refractory NHL (NCT02142530) | Massachusetts General Hospital | 2014-10-01 |
| Copanlisib Pharmacodynamic Study (NCT02155582) | Bayer | 2014-08-12 |
| Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention (NCT01951885) | Case Comprehensive Cancer Center | 2014-07-07 |
| Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma (NCT02141100) | Kjeld Schmiegelow | 2014-07-01 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors (NCT02080416) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-07-01 |
| Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) (NCT01853631) | Baylor College of Medicine | 2014-02-01 |
| Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy (NCT02371161) | Fondazione Italiana Linfomi - ETS | 2014-02-01 |
| A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) (NCT01953692) | Merck Sharp & Dohme LLC | 2013-11-22 |
| Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation (NCT01634217) | Masonic Cancer Center, University of Minnesota | 2013-11-08 |
| Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (NCT01956084) | Catherine Bollard | 2013-11-01 |
| Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies (NCT01998035) | Columbia University | 2013-11-01 |
| Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies (NCT01947140) | Jennifer Amengual | 2013-09-09 |
| Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma (NCT01939327) | Institut Paoli-Calmettes | 2013-09-01 |
| Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies (NCT01900509) | St. Jude Children's Research Hospital | 2013-08-01 |
| Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms (NCT01908387) | Celgene Corporation | 2013-07-01 |
| Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies (NCT01871675) | SCRI Development Innovations, LLC | 2013-05-01 |
| Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL) (NCT01685008) | MorphoSys AG | 2013-04-23 |
| Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL (NCT01914744) | Fudan University | 2013-02-01 |
| ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas (NCT01777152) | Seagen Inc. | 2013-01-31 |
| Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies (NCT01760655) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-12-24 |
| A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (NCT01796171) | Nordic Nanovector | 2012-12-01 |
| PEARL Study: Improvement of Non-Hodgkin's Lymphoma Care (NCT01562509) | Radboud University Medical Center | 2012-10-01 |
| Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies (NCT01527045) | Fred Hutchinson Cancer Center | 2012-09-25 |
| A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment (NCT01596621) | Teva Branded Pharmaceutical Products R&D, Inc. | 2012-08-06 |
| Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma (NCT01593696) | National Cancer Institute (NCI) | 2012-06-29 |
| BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma (NCT03794167) | Soonchunhyang University Hospital | 2012-06-01 |
| Double Cord Versus Haploidentical (BMT CTN 1101) (NCT01597778) | Medical College of Wisconsin | 2012-06-01 |
| Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma (NCT01482754) | National University Hospital, Singapore | 2012-05-01 |
| Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation (NCT01541072) | Centre Leon Berard | 2012-02-01 |
| Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases (NCT01447056) | Baylor College of Medicine | 2012-02-01 |
| Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL (NCT01333046) | Baylor College of Medicine | 2012-01-01 |
| Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT (NCT01810120) | Mariella Enoc | 2012-01-01 |
| Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia (NCT01516619) | Andres J. M. Ferreri | 2011-11-01 |
| Administration of Donor T Cells With the Caspase-9 Suicide Gene (NCT01494103) | Baylor College of Medicine | 2011-11-01 |
| Music Therapy on Nausea and Pain for Autologous Stem Cell (NCT01487031) | Case Comprehensive Cancer Center | 2011-11-01 |
| Providing Access to Cord Blood Units for Transplants (NCT01479582) | National Cancer Institute (NCI) | 2011-10-27 |
| A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) (NCT01351545) | Center for International Blood and Marrow Transplant Research | 2011-10-01 |
| Preservation of Ovarian Function After Hematopoietic Cell Transplant (NCT01343368) | Masonic Cancer Center, University of Minnesota | 2011-07-01 |
| A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma (NCT01328626) | AbbVie | 2011-05-23 |
| Phase I Study of OPB-51602 in Patients With Hematologic Malignancies (NCT01344876) | Otsuka Pharmaceutical Co., Ltd. | 2011-04-01 |
| Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents (NCT02488369) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-03-31 |
| Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation (NCT01283776) | University of Cologne | 2011-03-01 |
| 124I-FIAU Imaging in EBV and KSHV Associated Cancers (NCT00982449) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-12-01 |
| Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells (NCT01097057) | Fred Hutchinson Cancer Center | 2010-11-09 |
| Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma (NCT00992446) | Fred Hutchinson Cancer Center | 2010-09-02 |
| Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies (NCT01181258) | Masonic Cancer Center, University of Minnesota | 2010-08-01 |
| Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma (NCT01178645) | Seoul National University Hospital | 2010-07-01 |
| Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma (NCT01178658) | Seoul National University Hospital | 2010-07-01 |
| Relapsed and/or Refractory Non-Hodgkin Lymphoma Study (NCT00837174) | The Methodist Hospital Research Institute | 2010-06-01 |
| FNA Tumor Sampling for CD137 Modulation: A Pilot Study (NCT01114256) | Stanford University | 2010-03-01 |
| Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients (NCT01018979) | GPCR Therapeutics, Inc. | 2010-02-01 |
| Methionine PET/CT Studies In Patients With Cancer (NCT00840047) | St. Jude Children's Research Hospital | 2009-07-20 |
| Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab (NCT00946023) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-07-01 |
| T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL (NCT00709033) | Baylor College of Medicine | 2009-07-01 |
| Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma (NCT00928018) | Dana-Farber Cancer Institute | 2009-06-01 |
| A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies (NCT00923520) | National Cancer Institute (NCI) | 2009-03-25 |
| Unrelated Umbilical Cord Blood (UBC)Transplantation (NCT01768845) | West Virginia University | 2009-02-03 |
| Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture (NCT00808171) | Federal University of Minas Gerais | 2009-02-01 |
| Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma. (NCT01019863) | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 2008-10-01 |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients (NCT00859768) | Netherlands Open University | 2008-04-01 |
| Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR (NCT01611298) | Robert Krance | 2008-03-01 |
| Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) (NCT00626444) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-02-01 |
| Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL) (NCT00644371) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2007-11-01 |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE (NCT00578539) | Baylor College of Medicine | 2007-10-01 |
| Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen (NCT00556452) | University of Michigan Rogel Cancer Center | 2007-10-01 |
| Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (NCT00907348) | Fondazione Italiana Linfomi - ETS | 2007-10-01 |
| A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors (NCT00503451) | Novartis Pharmaceuticals | 2007-09-01 |
| A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin (NCT01164696) | Bayer | 2007-08-01 |
| Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD (NCT00539695) | Baylor College of Medicine | 2007-06-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 (NCT00471367) | AstraZeneca | 2007-04-01 |
| Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. (NCT00429065) | Instituto Nacional de Cancerologia de Mexico | 2007-01-01 |
| EMD 521873 in Advanced Solid Tumors, MTD Finding (NCT01032681) | Merck KGaA, Darmstadt, Germany | 2006-12-01 |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells (NCT00398411) | University of Cologne | 2006-10-01 |
| Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma (NCT00383097) | Baylor College of Medicine | 2006-09-01 |
| A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae (NCT01010295) | International Extranodal Lymphoma Study Group (IELSG) | 2006-09-01 |
| Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (NCT00509379) | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | 2006-09-01 |
| PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin (NCT00332202) | Eli Lilly and Company | 2006-06-01 |
| Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas (NCT00374699) | Samsung Medical Center | 2006-04-01 |
| Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma (NCT00302757) | University Hospital Tuebingen | 2006-03-01 |
| Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma (NCT00306111) | University Hospital Tuebingen | 2006-01-01 |
| Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease (NCT00719888) | Fred Hutchinson Cancer Center | 2005-11-18 |
| Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation (NCT00328237) | Colorado Blood Cancer Institute | 2005-11-01 |
| Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies (NCT00143559) | St. Jude Children's Research Hospital | 2005-08-01 |
| Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma (NCT01000753) | Children's Oncology Group | 2005-05-30 |
| Study of TPI 287 in Patients With Advanced Malignancies (NCT00113724) | Cortice Biosciences, Inc. | 2005-05-01 |
| A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma (NCT00103779) | Seagen Inc. | 2004-12-01 |
| CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas (NCT00185965) | Ronald Levy | 2004-07-01 |
| Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL (NCT00185445) | Genzyme, a Sanofi Company | 2004-06-01 |
| Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers (NCT00089596) | ViaCell | 2004-03-01 |
| Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training (NCT00196885) | German Cancer Research Center | 2003-12-01 |
| Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. (NCT00145652) | Sundsvall Hospital | 2003-12-01 |